Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-11-16
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ATRIOVENTRICULAR BLOCK FIRST DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-10 (study day 115.0); relationship: POSSIBLE
moderate
assessed
Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-10 (study day 115.0); relationship: POSSIBLE
Data queries
No data queries.